Merck Sharp & Dohme Limited

Hertford Road, Hoddesdon, Hertfordshire, EN11 9BU
Telephone: +44 (0)1992 467 272
Fax: +44 (0)1992 452 206
Medical Information e-mail: medicalinformationuk@merck.com
Patient Information Leaflet last updated on the eMC: 25/11/2009
PIL JANUVIA 100mg film-coated tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 25/11/2009 and displayed until Current
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 09/09/2009 and displayed until 25/11/2009
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to side-effects
Updated on 12/06/2009 and displayed until 09/09/2009
Reasons for adding or updating:
  • Change to Further Information section
  • Change to side-effects
Updated on 03/06/2008 and displayed until 12/06/2009
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 13/03/2008 and displayed until 03/06/2008
Reasons for adding or updating:
  • Change to side-effects
  • Change to warnings or special precautions for use
Updated on 17/01/2008 and displayed until 13/03/2008
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 23/10/2007 and displayed until 17/01/2008
Reasons for adding or updating:
  • Change to side-effects
Updated on 19/04/2007 and displayed until 23/10/2007
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   sitagliptin phosphate monohydrate


© 2010 Datapharm Communications Ltd

Go to www.medicines.org.uk